Hepatosplenic T-cell lymphoma: a rare but challenging entity
- PMID: 32756940
- PMCID: PMC7596851
- DOI: 10.1182/blood.2019004118
Hepatosplenic T-cell lymphoma: a rare but challenging entity
Abstract
Hepatosplenic T-cell lymphoma (HSTCL) is a rare T-cell neoplasm that most commonly arises from a small subset of γ/δ T-cell receptor-expressing lymphocytes. HSTCL is more common in adolescent and young adults and has a rapidly progressive clinical course and poor outcome due to its refractoriness to conventional chemotherapy regimens. Approximately 20% of the cases arise in the background of chronic immunosuppression or immune dysregulation. Patients commonly present with constitutional symptoms, hepatic and liver enlargement, and cytopenias; hematophagocytic syndrome can also occur. The most frequent chromosomal aberrations associated with HSTCL are isochromosome 7q and trisomy 8, and most cases harbor mutations in genes involved in chromatin modification or the JAK/STAT pathway. The rarity of this disease, along with lack of nodal involvement and presenting symptoms that mimic different entities including infectious etiologies, makes this lymphoma a significant diagnostic challenge. In this review, we highlight the clinical and pathologic features of HSTCL. Moreover, we summarize the results of recent molecular studies suggesting potential targets for novel therapeutics strategies.
© 2020 by The American Society of Hematology.
Conflict of interest statement
Conflict-of-interest disclosure: The authors declare no competing financial interests.
Figures
References
-
- Harris NL, Jaffe ES, Stein H, et al. . A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84(5):1361-1392. - PubMed
-
- Farcet JP, Gaulard P, Marolleau JP, et al. . Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood. 1990;75(11):2213-2219. - PubMed
-
- Gaulard P, Jaffe ES, Krenacs L, Macon WR. Hepatosplenic T-cell lymphoma In: Swerdlow SH, Campo E, Harris NL, eds., et al... WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Lyon, France: International Agency for Research on Cancer; 2017:381-382.
-
- Vose J, Armitage J, Weisenburger D; International T-Cell Lymphoma Project . International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26(25):4124-4130. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
